Oxervate 0.002% soln

Ended Awarded Last action

Contract number
36C25222F0128
Awardee
Awarding agency
Obligated
$0

Award facts

Contract value
$0.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
San Mateo, CA 94401, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00001 -$18,030
Original award $18,030

About this award

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a $0.00 delivery order to Dompe U.S. Inc. under the Pharmaceuticals and Drugs Federal Supply Schedule contract. The delivery order is for OXERVATE 0.002% solution and has a period of performance through July 5, 2023. No set-aside designation was used for this award made on February 18, 2022. The delivery order utilizes firm fixed pricing and will support the VA's provision of pharmaceutical products and medical services to veterans in the San Mateo, California area.

Quick answers

Who was awarded contract 36C25222F0128?

36C25222F0128 was awarded to Dompe U.s. Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on February 18, 2022.

How much is contract 36C25222F0128 worth?

The government has obligated $0 on 36C25222F0128.

Is contract 36C25222F0128 an order under another contract?

Yes. 36C25222F0128 is a delivery order under 36F79720D0017, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C25222F0128 competed?

The extent of competition for 36C25222F0128 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award